Dr. Keli Makela Turner, MD

Dr. Turner practices at Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care.

Dr. Turner's NPI, 1700045689, was assigned on June 5, 2008. Dr. Turner graduated from Vanderbilt University School Of Medicine in 2008. Dr. Turner's Tennessee license number on file is 60368.

Dr. Turner's primary practice is Baptist Memorial Hospital-Memphis, at 6019 Walnut Grove Road, Memphis, TN 38120 in Shelby County. The practice phone is (901) 226-5000.

Dr. Turner's primary practice is Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care. Dr. Turner is also affiliated with Baptist Memorial Hospital-DeSoto. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Turner to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Turner practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Turner's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Turner is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Turner's licenses on file in 4 states: Tennessee, Mississippi, Kentucky and New York.

Dmand AI lists abdominal adhesion surgery, colon removal and mastectomy among the conditions Dr. Turner treats.

CMS data shows 33 Medicare services from Dr. Turner across 2 procedure codes in 2024, all of them office visits, for 72 Medicare patients. Medicare paid $2,265 for them. Every service was in an office.

CMS counts 72 Medicare patients who saw Dr. Turner in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Turner's median patient age at 71, with 51% women.

In 2024, Dr. Turner wrote 41 Medicare Part D claims for 27 patients. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $94 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Turner for performance year 2024, reported as part of a group. Dr. Turner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Turner, published from 2013 to 2014. 2013 was the busiest year, with 2. The most frequent topics are Chemotherapy, Cancer, Regional Perfusion and Peritoneal Neoplasms. Dr. Turner's most frequent co-authors are Nader N. Hanna, MD, David Lawrence Bartlett, MD and Cherif Boutros, MD.

CMS Open Payments shows 48 general payments to Dr. Turner from 23 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Acera Surgical, Inc. paid the most, $226.

Dr. Turner graduated from Vanderbilt University School Of Medicine in 2008.

Dr. Turner is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.